CranioSense Awarded $5.5 Million in Federal Grants to Validate Noninvasive Neurotech
PR Newswire —
BOSTON, Dec. 17, 2025 /PRNewswire/ -- CranioSense, Inc., a neurotechnology company developing the world's first noninvasive intracranial pressure (ICP) diagnostic and monitoring system, today announced the award of approximately $5.5 million in total non-dilutive funding through the NIH...